DYSKINESIA
Cipla makes additional investment in German mRNA biotechEthris' has four potential drugs under development pipeline, of which one is for treating uncontrolled asthma and three other for primary c...18 Jun, 2024, 07.44 PM IST
Lupin gets USFDA nod to market generic medicationLupin has gained approval from the USFDA to market generic Valbenazine Capsules, used to treat tardive dyskinesia. This medication is equiv...08 Apr, 2024, 04.16 PM IST
Zydus Lifesciences gets USFDA nod for 2 generic drugsThe tentative approval granted by the US Food and Drug Administration (USFDA) to the company's arm Zydus Worldwide DMCC to market Valbenazi...17 Oct, 2022, 01.52 PM IST
Load More